Cassandra Sauer , Mai-Anh Hoang , Hou Kroeun , Aman Sen Gupta , Rem Ngik , Meng Sokchea , Jocelyne M Labonté , Mary Chea , Rolf Klemm , Ashutosh Mishra , Aishwarya Panicker , Vin Sokhal , Crystal D Karakochuk
{"title":"评估怀孕期间铁和叶酸与多种微量营养素补充剂的依从性和可接受性:柬埔寨的一项集群随机非劣效性试验。","authors":"Cassandra Sauer , Mai-Anh Hoang , Hou Kroeun , Aman Sen Gupta , Rem Ngik , Meng Sokchea , Jocelyne M Labonté , Mary Chea , Rolf Klemm , Ashutosh Mishra , Aishwarya Panicker , Vin Sokhal , Crystal D Karakochuk","doi":"10.1016/j.ajcnut.2025.04.033","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The Cambodian Ministry of Health is exploring transitioning from iron and folic acid (IFA) to multiple micronutrient supplements (MMS) during pregnancy and is seeking rigorous evidence to inform this policy change.</div></div><div><h3>Objective</h3><div>We aimed to assess the adherence and acceptability of MMS compared with IFA supplementation during pregnancy.</div></div><div><h3>Methods</h3><div>We conducted an open-label cluster-randomized noninferiority trial across 48 health centers in Cambodia. A total of 1546 healthy pregnant individuals (18–45 y) were recruited at their first antenatal care (ANC) visit (<14 weeks of gestation) and randomized to 1 of 3 arms at the health center level: <em>1</em>) IFA for 90 d (IFA-90, <em>n</em> = 515), the current standard of care; <em>2</em>) MMS for 180 d via 1 180-tablet bottle (MMS-180, <em>n</em> = 516); or 3) MMS for 180 d via 2 90-tablet bottles (MMS-90, <em>n</em> = 515). Our primary outcome was the noninferiority of adherence rates of MMS-180 compared with IFA-90, assessed by tablet counts and compared against a predefined noninferiority margin of −15%. Mixed-effects linear regression models were used to estimate the mean difference (95% confidence interval [95% CI]) in adherence rates. Our secondary outcomes included the mean difference in ANC attendance between the MMS groups and the acceptability of MMS across 6 domains.</div></div><div><h3>Results</h3><div>Overall, 88% of participants completed the trial, with high mean adherence rates across arms (91% for IFA-90, 95% for MMS-180, and 95% for MMS-90). The adjusted mean (95% CI) difference in adherence rates between MMS-180 and IFA-90 groups was 3.9% (1.7, 6.2). The adjusted mean (95% CI) difference in ANC visits for MMS-180 and MMS-90 groups was 0.0 (−0.1, 0.2) visits. The acceptability of MMS was positive (90%–100% “agreement” across 6 domains).</div></div><div><h3>Conclusions</h3><div>Both IFA and MMS were highly acceptable, yet adherence to MMS was superior to IFA. These findings support the transition from IFA to MMS in Cambodia.</div><div>This trial was registered at <span><span>Clinicaltrials.gov</span><svg><path></path></svg></span> as NCT05867836.</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"122 1","pages":"Pages 166-173"},"PeriodicalIF":6.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia\",\"authors\":\"Cassandra Sauer , Mai-Anh Hoang , Hou Kroeun , Aman Sen Gupta , Rem Ngik , Meng Sokchea , Jocelyne M Labonté , Mary Chea , Rolf Klemm , Ashutosh Mishra , Aishwarya Panicker , Vin Sokhal , Crystal D Karakochuk\",\"doi\":\"10.1016/j.ajcnut.2025.04.033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The Cambodian Ministry of Health is exploring transitioning from iron and folic acid (IFA) to multiple micronutrient supplements (MMS) during pregnancy and is seeking rigorous evidence to inform this policy change.</div></div><div><h3>Objective</h3><div>We aimed to assess the adherence and acceptability of MMS compared with IFA supplementation during pregnancy.</div></div><div><h3>Methods</h3><div>We conducted an open-label cluster-randomized noninferiority trial across 48 health centers in Cambodia. A total of 1546 healthy pregnant individuals (18–45 y) were recruited at their first antenatal care (ANC) visit (<14 weeks of gestation) and randomized to 1 of 3 arms at the health center level: <em>1</em>) IFA for 90 d (IFA-90, <em>n</em> = 515), the current standard of care; <em>2</em>) MMS for 180 d via 1 180-tablet bottle (MMS-180, <em>n</em> = 516); or 3) MMS for 180 d via 2 90-tablet bottles (MMS-90, <em>n</em> = 515). Our primary outcome was the noninferiority of adherence rates of MMS-180 compared with IFA-90, assessed by tablet counts and compared against a predefined noninferiority margin of −15%. Mixed-effects linear regression models were used to estimate the mean difference (95% confidence interval [95% CI]) in adherence rates. Our secondary outcomes included the mean difference in ANC attendance between the MMS groups and the acceptability of MMS across 6 domains.</div></div><div><h3>Results</h3><div>Overall, 88% of participants completed the trial, with high mean adherence rates across arms (91% for IFA-90, 95% for MMS-180, and 95% for MMS-90). The adjusted mean (95% CI) difference in adherence rates between MMS-180 and IFA-90 groups was 3.9% (1.7, 6.2). The adjusted mean (95% CI) difference in ANC visits for MMS-180 and MMS-90 groups was 0.0 (−0.1, 0.2) visits. The acceptability of MMS was positive (90%–100% “agreement” across 6 domains).</div></div><div><h3>Conclusions</h3><div>Both IFA and MMS were highly acceptable, yet adherence to MMS was superior to IFA. These findings support the transition from IFA to MMS in Cambodia.</div><div>This trial was registered at <span><span>Clinicaltrials.gov</span><svg><path></path></svg></span> as NCT05867836.</div></div>\",\"PeriodicalId\":50813,\"journal\":{\"name\":\"American Journal of Clinical Nutrition\",\"volume\":\"122 1\",\"pages\":\"Pages 166-173\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Clinical Nutrition\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0002916525002503\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Clinical Nutrition","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002916525002503","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia
Background
The Cambodian Ministry of Health is exploring transitioning from iron and folic acid (IFA) to multiple micronutrient supplements (MMS) during pregnancy and is seeking rigorous evidence to inform this policy change.
Objective
We aimed to assess the adherence and acceptability of MMS compared with IFA supplementation during pregnancy.
Methods
We conducted an open-label cluster-randomized noninferiority trial across 48 health centers in Cambodia. A total of 1546 healthy pregnant individuals (18–45 y) were recruited at their first antenatal care (ANC) visit (<14 weeks of gestation) and randomized to 1 of 3 arms at the health center level: 1) IFA for 90 d (IFA-90, n = 515), the current standard of care; 2) MMS for 180 d via 1 180-tablet bottle (MMS-180, n = 516); or 3) MMS for 180 d via 2 90-tablet bottles (MMS-90, n = 515). Our primary outcome was the noninferiority of adherence rates of MMS-180 compared with IFA-90, assessed by tablet counts and compared against a predefined noninferiority margin of −15%. Mixed-effects linear regression models were used to estimate the mean difference (95% confidence interval [95% CI]) in adherence rates. Our secondary outcomes included the mean difference in ANC attendance between the MMS groups and the acceptability of MMS across 6 domains.
Results
Overall, 88% of participants completed the trial, with high mean adherence rates across arms (91% for IFA-90, 95% for MMS-180, and 95% for MMS-90). The adjusted mean (95% CI) difference in adherence rates between MMS-180 and IFA-90 groups was 3.9% (1.7, 6.2). The adjusted mean (95% CI) difference in ANC visits for MMS-180 and MMS-90 groups was 0.0 (−0.1, 0.2) visits. The acceptability of MMS was positive (90%–100% “agreement” across 6 domains).
Conclusions
Both IFA and MMS were highly acceptable, yet adherence to MMS was superior to IFA. These findings support the transition from IFA to MMS in Cambodia.
This trial was registered at Clinicaltrials.gov as NCT05867836.
期刊介绍:
American Journal of Clinical Nutrition is recognized as the most highly rated peer-reviewed, primary research journal in nutrition and dietetics.It focuses on publishing the latest research on various topics in nutrition, including but not limited to obesity, vitamins and minerals, nutrition and disease, and energy metabolism.
Purpose:
The purpose of AJCN is to:
Publish original research studies relevant to human and clinical nutrition.
Consider well-controlled clinical studies describing scientific mechanisms, efficacy, and safety of dietary interventions in the context of disease prevention or health benefits.
Encourage public health and epidemiologic studies relevant to human nutrition.
Promote innovative investigations of nutritional questions employing epigenetic, genomic, proteomic, and metabolomic approaches.
Include solicited editorials, book reviews, solicited or unsolicited review articles, invited controversy position papers, and letters to the Editor related to prior AJCN articles.
Peer Review Process:
All submitted material with scientific content undergoes peer review by the Editors or their designees before acceptance for publication.